ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.188,34
-1,00%
S&P 500
5.214,08
0,51%
US Dollar vs BRL
5,1423
0,00%
Bitcoin
62.805,21
-0,39%
Brent Oil
84,035
0,10%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Canadá
  5. TSXV
  6. ICO Therapeutics Inc (ICO)

  7. ICO Therapeutics Inc (ICO) Notícias

ICO

ICO Therapeutics (ICO)

ICO Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:TSXV:ICO
DataHoraFonteTítuloCódigoCompanhia
17/08/202118:30PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - ICOTSXV:ICOICO Therapeutics Inc
17/08/202118:24PR Newswire (Canada)IIROC Trading Resumption - ICOTSXV:ICOICO Therapeutics Inc
22/03/202109:05PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - ICOTSXV:ICOICO Therapeutics Inc
22/03/202109:03PR Newswire (Canada)IIROC Trading Halt - ICOTSXV:ICOICO Therapeutics Inc
25/05/201617:00PR Newswire (Canada)iCo Therapeutics Announces First Quarter 2016 Financial ResultsTSXV:ICOICO Therapeutics Inc
14/04/201617:00PR Newswire (Canada)iCo Therapeutics Announces Year End 2015 Financial ResultsTSXV:ICOICO Therapeutics Inc
17/02/201620:35PR Newswire (Canada)iCo Therapeutics Inc. Announces Grant of Stock Options and Recent CEO Share PurchasesTSXV:ICOICO Therapeutics Inc
18/01/201610:00PR Newswire (Canada)iCo Strategic ReorganizationTSXV:ICOICO Therapeutics Inc
24/12/201510:00PR Newswire (Canada)iCo Therapeutics Announces Changes to Board of DirectorsTSXV:ICOICO Therapeutics Inc
24/11/201522:21PR Newswire (Canada)/C O R R E C T I O N from Source -- iCo Therapeutics Inc./TSXV:ICOICO Therapeutics Inc
24/11/201520:00PR Newswire (Canada)iCo Therapeutics Announces Third Quarter 2015 Financial ResultsTSXV:ICOICO Therapeutics Inc
26/10/201510:00PR Newswire (Canada)iCo Therapeutics Announces Manufacturing Update for Oral Amp B ProgramTSXV:ICOICO Therapeutics Inc
26/08/201518:00PR Newswire (Canada)iCo Therapeutics Announces Second Quarter 2015 Financial ResultsTSXV:ICOICO Therapeutics Inc
26/06/201517:00PR Newswire (Canada)iCo Therapeutics Announces Voting & Election Results from Annual Meeting of ShareholdersTSXV:ICOICO Therapeutics Inc
28/05/201518:00PR Newswire (Canada)iCo Therapeutics Announces First Quarter 2015 Financial ResultsTSXV:ICOICO Therapeutics Inc
27/04/201518:00PR Newswire (Canada)iCo Therapeutics Announces Year End 2014 Financial ResultsTSXV:ICOICO Therapeutics Inc
17/04/201516:15PR Newswire (Canada)iCo Therapeutics Inc. Comments on Recent Market ActivityTSXV:ICOICO Therapeutics Inc
28/11/201420:00PR Newswire (Canada)iCo Therapeutics Announces Third Quarter 2014 Financial Results and Corporate UpdateTSXV:ICOICO Therapeutics Inc
04/11/201410:00PR Newswire (Canada)iCo Therapeutics Announces Oral Amphotericin Presentations at AAPSTSXV:ICOICO Therapeutics Inc
22/10/201409:00PR Newswire (Canada)iCo Therapeutics Announces Advancement of Oral Amphotericin B ProgramTSXV:ICOICO Therapeutics Inc
29/08/201408:00PR Newswire (Canada)iCo Therapeutics Announces Second Quarter 2014 Financial ResultsTSXV:ICOICO Therapeutics Inc
19/08/201408:00PR Newswire (Canada)iCo Therapeutics Announces Positive Oral Amphotericin B Study ResultsTSXV:ICOICO Therapeutics Inc
15/07/201414:29PR Newswire (Canada)iCo Therapeutics Inc. - No Material ChangeTSXV:ICOICO Therapeutics Inc
30/06/201408:00PR Newswire (Canada)iCo Therapeutics Announces Director Election Results From Its Annual Meeting of ShareholdersTSXV:ICOICO Therapeutics Inc
09/06/201409:00PR Newswire (Canada)iCo Therapeutics Announces Top-Line Primary Endpoint Data from iCo-007 Phase 2 iDEAL Study in Diabetic Macular EdemaTSXV:ICOICO Therapeutics Inc
29/05/201418:00PR Newswire (Canada)iCo Therapeutics Announces First Quarter 2014 Financial ResultsTSXV:ICOICO Therapeutics Inc
29/04/201408:00PR Newswire (Canada)iCo Therapeutics Announces Poster Presentation at ARVOTSXV:ICOICO Therapeutics Inc
24/04/201418:00PR Newswire (Canada)iCo Therapeutics Announces Year End 2013 Financial ResultsTSXV:ICOICO Therapeutics Inc
26/03/201409:45Marketwired CanadaTrue Drinks Announces Scot Cohen as New DirectorTSXV:ICOICO Therapeutics Inc
05/03/201409:00PR Newswire (Canada)iCo Therapeutics Announces Final Eight Month Patient Visit in Phase 2 iDEAL StudyTSXV:ICOICO Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:TSXV:ICO

Seu Histórico Recente

BOV
VVEO3
CM Hospitalar ON
BOV
HBRE3
HBR Realty Empreendiment... ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
TELB4
TELEBRAS PN
BOV
IBOV
Índice Bovespa
BOV
CASH3
Meliuz S.A ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
PRIO3
PETRORIO ON
BOV
COGN3
COGNA ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados